Yanhua Ding Selected Research

Formoterol Fumarate (Oxis)

3/2022

An Evaluation of the Pharmacokinetics, Safety, and Tolerability of Aclidinium/Formoterol Fixed-Dose Combination Administered in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanhua Ding Research Topics

Disease

15	Infections 02/2024 - 10/2013
10	Chronic Hepatitis B 01/2023 - 10/2013
5	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2020
4	Neoplasms (Cancer) 01/2024 - 01/2021
4	Chronic Hepatitis C 11/2020 - 01/2012
4	Virus Diseases (Viral Diseases) 11/2020 - 01/2013
2	Non-alcoholic Fatty Liver Disease 10/2023 - 10/2022
2	Drug-Related Side Effects and Adverse Reactions 10/2023 - 12/2020
2	Human Influenza (Influenza) 01/2023 - 11/2021
2	Fibrosis (Cirrhosis) 10/2021 - 11/2020
2	Hypertension (High Blood Pressure) 03/2021 - 01/2020
2	Disease Progression 01/2021 - 11/2019
2	Hepatitis C 11/2019 - 01/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2023
1	Diarrhea 10/2023
1	Headache (Headaches) 10/2023
1	Neoplasm Metastasis (Metastasis) 10/2023
1	Common Cold 01/2023
1	Photosensitivity Disorders (Photodermatitis) 10/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2022
1	Fatty Liver 10/2022
1	Obesity 10/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Hypercholesterolemia 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Nausea 01/2022
1	Ascites 10/2021
1	Ankylosing Spondylitis 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Rabies (Hydrophobia) 12/2020

Drug/Important Bio-Agent (IBA)

9	Antiviral Agents (Antivirals)IBA 01/2023 - 03/2016
4	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2019
4	SofosbuvirIBA 11/2020 - 01/2018
3	Monoclonal AntibodiesIBA 12/2023 - 01/2021
3	InterferonsIBA 11/2020 - 03/2016
2	Analgesics (Analgesic Drugs)IBA 01/2023 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2020
2	pradefovirIBA 10/2022 - 01/2020
2	Tenofovir (Viread)FDA Link 01/2022 - 01/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2022
2	Alanine Transaminase (SGPT)IBA 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 10/2021 - 07/2018
2	SodiumIBA 12/2020 - 01/2020
2	rongliflozinIBA 01/2020 - 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2024
1	Amoxicillin (Wymox)FDA LinkGeneric 02/2024
1	Enteric-Coated Tablets (Tablets, Enteric Coated)IBA 02/2024
1	Rabeprazole (Aciphex)FDA Link 02/2024
1	Tumor Biomarkers (Tumor Markers)IBA 01/2024
1	Cancer VaccinesIBA 01/2024
1	Phosphodiesterase InhibitorsIBA 10/2023
1	CreatinineIBA 10/2023
1	Denosumab FDA Link 10/2023
1	human ERBB2 proteinIBA 06/2023
1	phillyrinIBA 01/2023
1	Hepatitis B AntigensIBA 01/2023
1	AntipyreticsIBA 01/2023
1	Interferon Type IIBA 01/2023
1	N-phenylglycineIBA 10/2022
1	Hepatitis B e AntigensIBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	aclidinium bromideIBA 03/2022
1	Formoterol Fumarate (Oxis)FDA Link 03/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	Atorvastatin (Lipitor)FDA Link 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	GST-HG131IBA 01/2022
1	ProdrugsIBA 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2021
1	ZSP1273IBA 11/2021
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 11/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2021
1	Human Serum Albumin FDA LinkGeneric 10/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2021
1	Calcium Channels (Calcium Channel)IBA 03/2021
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 03/2021
1	MT-1207IBA 03/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	chiglitazarIBA 01/2021
1	Mesylates (Mesylate)IBA 01/2021
1	serotonin 6 receptorIBA 01/2021
1	Humanized Monoclonal AntibodiesIBA 12/2020
1	janagliflozinIBA 12/2020
1	VaccinesIBA 12/2020
1	sofosbuvir drug combination ledipasvirIBA 01/2020
1	velpatasvirIBA 01/2020

Therapy/Procedure

4	Therapeutics 02/2024 - 01/2020
1	Oral Administration 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Injections 12/2020